Baminercept in Sjogren's Syndrome (ASJ02)

The purpose of the study is to find out if the experimental study agent, baminercept, is effective in treating patients with Sjogren's syndrome. The study will also determine if the study agent can be safely given to patients with Sjogren's syndrome; examine how it affects symptoms of the disease; and attempt to understand how baminercept affects the underlying mechanisms of Sjogren's syndrome and the immune system.